Irinotecan in Treating Patients With Advanced Gallbladder or Bile Duct Cancer

NCT00003276 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Gallbladder Cancer

Interventions

DRUG: irinotecan hydrochloride

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]